NCT00386165View on ClinicalTrials.gov

Safety Study of Larazotide Acetate to Treat Celiac Disease.

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

November 29, 2005

Primary Completion Date

January 26, 2006

Study Completion Date

January 26, 2006

Conditions
Celiac Disease
Interventions
DRUG

larazotide acetate

larazotide acetate 4 mg capsules

Trial Locations (1)

21225

Parexel, Baltimore

Sponsors
All Listed Sponsors
lead

9 Meters Biopharma, Inc.

INDUSTRY